Copyright
©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. May 6, 2017; 8(2): 137-146
Published online May 6, 2017. doi: 10.4292/wjgpt.v8.i2.137
Published online May 6, 2017. doi: 10.4292/wjgpt.v8.i2.137
Patients | n = 462 |
Severe AEs | |
Any AE1 | 11 (2.4) |
AEs | 321 (69.5) |
Fatigue | 104 (22.5) |
Headache | 55 (11.7) |
Anemia | 52 (11.3) |
Insomnia | 23 (5.0) |
Infection | 20 (4.3) |
Arthralgia, myalgia | 19 (4.1) |
Dyspepsia | 15 (3.2) |
Rash | 14 (3.0) |
Deaths | 0 (0.0) |
- Citation: Ramos H, Linares P, Badia E, Martín I, Gómez J, Almohalla C, Jorquera F, Calvo S, García I, Conde P, Álvarez B, Karpman G, Lorenzo S, Gozalo V, Vásquez M, Joao D, de Benito M, Ruiz L, Jiménez F, Sáez-Royuela F, Asociación Castellano y Leonesa de Hepatología (ACyLHE). Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world setting. World J Gastrointest Pharmacol Ther 2017; 8(2): 137-146
- URL: https://www.wjgnet.com/2150-5349/full/v8/i2/137.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v8.i2.137